AbbVie Non-GAAP EPS of $3.82 beats by $0.05, revenue of $17.4B beats by $50M, raises FY guidance
Read original article on Breaking News on Seeking Alpha →Related news
-
Cboe trades higher as derivatives revenue helps Q3 earnings; 2026 revenue guidance raised
Business
Corporate
United States
- Mobile-health Network Solutions reports FY results Business Corporate
- Red River Bancshares GAAP EPS of $1.90 beats by $0.07, revenue of $34.8M beats by $0.53M Business Corporate United States
- Newell Brands' Q3 sales beat overshadowed by margin pressure Business Corporate United States
-
Arbor Realty stock tumbles after dividend suspension, even as Q3 earnings beat
Business
Corporate
United States
-
enVVeno Medical GAAP EPS of -$6.29 misses by $3.94
Business
Corporate
-
AutoNation revenue beats estimates despite decline in vehicle sales
Business
Corporate
United States
- OPay prices US IPO at $19 per ADS Business Corporate United States